Kitamura M, Wada N, Nagata S, Iizuka N, Jin Y-F, Tomoeda M, et al
The most common experience during week 1 includes: Mild-to-moderate nausea, especially after eating Reduced appetite and an earlier feeling of fullness Possible fatigue or low energy as calorie intake drops Mild headache, often linked to reduced food and fluid intake The starting dose for Ozempic is 0.25 mg weekly
A patient could potentially benefit from combining hormonal therapy with GLP-1 treatment, addressing different aspects of the disease simultaneously
:
Important safety considerations include risks of pancreatitis, gallbladder disease, worsening of diabetic retinopathy (particularly with rapid improvement in blood glucose), and potential kidney injury if dehydration occurs due to gastrointestinal side effects